Skip to main content

Research Repository

Advanced Search

Outcomes of 1.3 million patients undergoing percutaneous coronary intervention according to the presence of cancer and atrial fibrillation: a retrospective study.

Istanbuly, Sedralmontaha; Matetić, Andrija; Bang, Vijay; Sharma, Kamal; Golwala, Harsh; Kheiri, Babikir; Osman, Mohammed; Swamy, Pooja; Bharadwaj, Aditya; Mamas, Mamas A

Authors

Sedralmontaha Istanbuly

Andrija Matetić

Vijay Bang

Kamal Sharma

Harsh Golwala

Babikir Kheiri

Mohammed Osman

Pooja Swamy

Aditya Bharadwaj



Abstract

To evaluate outcomes after percutaneous coronary intervention (PCI) in patients with cancer and atrial fibrillation (AF). Data of all adult discharges undergoing PCI between October 2015 and December 2018 were obtained from the National Inpatient Sample (NIS) database. Adjusted odds ratios (aOR) of adverse complications were calculated using binominal logistic regression. 1387320 patients were detected, out of which 15.4% had AF but no cancer, 1.9% had cancer but no AF, and 0.6% had both cancer and AF. Compared with cancer patients without AF, those with AF had a greater aOR of mortality (aOR 1.20, 95%CI 1.08-1.33), major adverse cardiac and cerebrovascular events (MACCE) (aOR 1.18, 95%CI 1.07-1.29), and bleeding (aOR 1.23, 95%CI 1.08-1.39). However, the risk of ischemic stroke was similar between the two groups. Patients with solid cancer and AF had a higher aOR for all outcomes, including mortality (aOR 1.28, 95%CI 1.09-1.50), MACCE (aOR 1.37, 95%CI 1.19-1.57), ischemic stroke (aOR 1.48, 95%CI 1.10-1.99), and bleeding (aOR 1.66, 95%CI 1.39-1.98) compared with the solid cancer group without AF. In patients with hematological cancer, AF was associated only with significantly increased risk of mortality (aOR 1.40, 95%CI 1.16-1.70) and MACCE (aOR 1.26, 95%CI 1.06-1.49). The presence of AF in solid cancer patients increases the risk of mortality, MACCE, stroke, and major bleeding, while in the setting of hematological cancer it is only associated with a higher risk of mortality and MACCE.

Citation

Istanbuly, S., Matetić, A., Bang, V., Sharma, K., Golwala, H., Kheiri, B., Osman, M., Swamy, P., Bharadwaj, A., & Mamas, M. A. (2024). Outcomes of 1.3 million patients undergoing percutaneous coronary intervention according to the presence of cancer and atrial fibrillation: a retrospective study. Croatian Medical Journal, 65(5), 405-416

Journal Article Type Article
Acceptance Date Sep 11, 2024
Online Publication Date Oct 31, 2024
Publication Date Oct 31, 2024
Deposit Date Nov 28, 2024
Journal Croatian medical journal
Print ISSN 0353-9504
Electronic ISSN 1332-8166
Publisher School of Medicine
Peer Reviewed Peer Reviewed
Volume 65
Issue 5
Pages 405-416
Keywords Treatment Outcome, Adult, Postoperative Complications - epidemiology - etiology, Middle Aged, Aged, Male, Humans, Female, Retrospective Studies, Aged, 80 and over, Hemorrhage - epidemiology - etiology, Percutaneous Coronary Intervention - adverse effects, Neoplasms - epidemiology, Risk Factors, Atrial Fibrillation - epidemiology
Public URL https://keele-repository.worktribe.com/output/980952
Publisher URL https://pmc.ncbi.nlm.nih.gov/articles/PMC11568383/